considering the recent rediscovery of the use of alpha-blocking agents in the treatment of hypertension and heart failure , we have studied the haemodynamic effects of 10-methyl-1,6-dimethyl-ergoline-8 beta-methanol- ( 5-bromonicotinate ( nicergoline , sermion ) , a new alpha-blocking ergot derivative , on the closed-chest anesthetized dog .
C0018801
heart failure
C0817096
chest